sublingual dust mite extract/immunotherapy (Odactra)
Jump to navigation
Jump to search
Indications
- allergic rhinitis &/or conjunctivitis due to dust mites (Odactra FDA-approved March 2017)
Dosage
- sublingual once daily year round
- may take 8-14 weeks before benefits observed[2]
More general terms
References
- ↑ Bergmann K-C et al. Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis. J Allergy Clin Immunol 2014 Jun; 133:1608 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/24388010 <Internet> http://www.jacionline.org/article/S0091-6749%2813%2901773-9/abstract
- ↑ Jump up to: 2.0 2.1 Brown T Odactra First Sublingual Therapy OK'd for House Dust Mite Allergy. Medscape. Mar 01, 2017 http://www.medscape.com/viewarticle/876513
FDA News Release. March 1, 2017 FDA approves Odactra for house dust mite allergies. https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm544330.htm